Objective. The aim of this study was to determine whether the proportions of naive and memory CD4 + T cell are independently associated with the metabolic syndrome (MetS) in patients with SLE.
Results. One hundred and seventeen patients were evaluated. Their mean age was 44.6 years (S.D. 12.6), 109 (93.2%) were female and all patients were Mestizo (mixed Caucasian and Amerindian ancestry). Fifty-two patients (44.4%) presented with MetS. Disease duration was 7.6 years (S. Conclusion. In the SLE patients studied, a lower percentage of naive CD4 + T cells, a higher percentage of memory CD4 + T cells and the memory:naive CD4 + T cell ratio were independently associated with the presence of MetS. This association could reflect the impact of immunosenescence among SLE patients with cardiovascular morbidity.
Introduction
Patients with SLE have a nearly 3-fold increased risk of allcause mortality and cardiovascular mortality [1] . Despite the fact that all-cause mortality has decreased over time, cardiovascular mortality has not [2] . In addition, SLE patients have at least a 2-to 3-fold increased risk of cardiovascular disease (CVD) [1] . In the general population, an intermediate outcome of CVD is the occurrence of metabolic syndrome (MetS), which in turn is associated with an at least 2-fold increased risk of CVD mortality and a 1.5-fold increased risk of all-cause mortality [3] .
In SLE, traditional risk factors like the Framingham risk score failed to predict CVD in a study conducted in England, underestimating it by a factor of six [4] , suggesting the existence of one or several lupus factors. The prevalence of MetS is higher in SLE patients than in the general population, varying between 18% and almost 40% depending on the definition used [5] . Hypertension and dyslipidaemia are the most common components of MetS present in SLE patients [6] , suggesting that SLE can lead to a more inflammatory MetS phenotype. This phenotype could reflect chronic immune system activation that can be expressed as a higher frequency of memory CD4 + T cells and a lower frequency of naive CD4 + T cells. In the general population, a higher frequency of memory CD4 + T cells has been associated with MetS [7] . Furthermore, atherosclerosis has been associated with higher levels of memory CD4 + T cells and lower levels of naive CD4 + T cells [8] . However, the association between memory and naive CD4 + T cells with MetS has not been examined in patients with SLE. The aim of the present study was to evaluate the association between naive and memory CD4 + T cell populations and the memory:naive CD4 + T cell ratio with MetS in SLE patients.
Methods

Patients
Since January 2012, all SLE patients presenting to the rheumatology department of the Guillermo Almenara Irigoyen Hospital in Lima, Peru have been invited to participate in the Almenara lupus cohort. The study was approved by the Institutional Review Board of the Guillermo Almenara Irigoyen Hospital. Patients who signed an informed consent form were recruited into this cohort and followed up every 6 months with a standard protocol that included an interview, medical records review, physical examination and laboratory tests. SLE was defined using the revised and updated ACR criteria; demographic data included were gender, age at diagnosis, marital status, education level and socio-economic status (SES). Disease duration was calculated from the time four of the revised and updated ACR criteria were fulfilled. SES was defined using the Graffar scale.
Clinical variables included were disease activity (ascertained with the SLEDAI), disease damage [ascertained with the SLICC/ACR damage index (SDI)], disease duration, age at diagnosis, tobacco use and co-morbidities.
Laboratory variables included were complete blood cell count, serum creatinine level, liver tests, random glucose levels, lipid profile, protein, complement, coagulation tests, CRP level, thyroid tests, prolactin levels, 24 h urinary protein, aPL and other autoantibodies. Therapeutic variables included were glucocorticoid (recorded as the current daily dose and time of exposure), antimalarial and immunosuppressive drug use (recorded as current, past or never).
MetS definition
MetS was defined according to the 2009 joint interim statement from the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society and International Association for the Study of Obesity [9] . This harmonizing statement requires three or more of the following five criteria to be present: (i) elevated waist circumference (MetS WC) of 580 cm in women and 590 cm in men (according to a population-specific threshold); (ii) elevated triglycerides 5150 mg/dl or drug therapy for hypertriglyceridaemia (MetS TG); (iii) high-density lipoprotein (HDL) cholesterol <50 mg/dl in women and <40 mg/dl in men or drug therapy to reduce HDL cholesterol (MetS HDL); (iv) elevated blood pressure 5130/85 mmHg or drug therapy for hypertension (MetS BP) and (v) elevated fasting glucose 5100 mg/dl or drug therapy for hyperglycaemia (MetS Glu).
Flow cytometry EDTA-treated peripheral blood was analysed using a lysewash method. To examine the expression of CD4, we used Alexa Fluor 647labelled anti-CD4 in combination with peridinin-chlorophyll protein complexlabelled anti-CD45, R-phycoerythrin anti-CD45RA and fluorescein isothiocyanate isomer 1labelled anti-CD45RO (all the above reagents were obtained from AbD Serotec, Oxford, UK). The various subsets are defined as CD4 + and either
. Analysis was performed using the FACSCalibur flow cytometer and CellQuest Pro software (BD, San Jose, CA, USA).
Statistical analyses
Categorical variables were summarized as frequency and percentage, while continuous variables are presented as mean (S.D.). The association between the T cell subpopulation and MetS (overall and its individual components) was examined using the MannWhitney U-test. Factors associated with the presence of MetS were examined using the chi-square or MannWhitney U-test, as appropriate. This was followed by multivariable logistic regression analysis adjusted for age, gender, disease duration, SES, tobacco use, CRP level, SLEDAI, SDI and the use of prednisone, antimalarials or immunosuppressive drugs. All statistical analyses were performed using SPSS version 21.0 (IBM, Armonk, NY, USA).
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Results
One hundred and seventeen patients were evaluated. There were no statistically significant differences among this group and the members of the Almenara lupus cohort not included in this study (data not shown). Their mean age was 44.6 years (S.D. 12.6), 109 (93.2%) were female and all patients were Mestizo (mixed Caucasian and Amerindian ancestry). The characteristics of patients included in this analysis are described in Table 1 On the other hand, naive CD4 + T cells decrease from nearly 100% in newborns to <30% in centenarians; these changes being indicative of senescence of the immune system [10] . Lower levels of naive and higher levels of memory CD4 + T cells have been associated with a more pro-inflammatory profile, in particular, with CVD, including MetS [7] , and atherosclerosis [8] . The association between CD4 + T cell subpopulations and cardiovascular morbidity, including MetS, could be explained by chronic inflammation, which can be caused by chronic infections like CMV [8] and Helicobacter pylori [8] ; these infections have been associated with an increase in memory and a decrease in naive CD4 + T cells, and also with atherosclerosis [11] . In addition, T cells, mainly memory, have been found in atheroma plaques [12] . In SLE patients, information about CD4 + T cell subpopulations is scarce; a lower percentage of naive CD4 + T cells has been found [13, 14] , particularly in patients with active renal disease [14] . In addition, there is a trend towards a higher proportion of memory CD4 + T cells, in particular in patients with active SLE [15] . In addition, Ammirati et al. [16] reported an analysis of the factors associated with common carotid intima-media thickness (IMT), which included immune factors such as CD4 + T cell subpopulations. In this study, no association between CD4 + T cell subpopulations and IMT was found;
however, this could be related to the relatively small number of patients studied (n = 50). Data from autoimmune processes other than lupus have some bearing on our findings. For example, in IgM RF-positive RA patients, an increase in memory and a decrease in naive CD4 + T cells has been associated with more aggressive disease [17] . In patients with SS a lower frequency of naive CD4 + T cells than in healthy controls has been reported [13] . Finally, in APS, memory CD4 + T cells positively correlated with carotid IMT [18] . These data taken together suggest that autoimmune processes can induce an increase in memory and a decrease in naive CD4 + T cells, which in turn could increase the risk of cardiovascular morbidity. The prevalence of MetS among our patients ($44%), which is higher than reported previously (1638%) [5] , is probably due to the lower cut-off points used for some of the criteria in accordance with the new definition of MetS. Parker et al. [19] , using the same definition as we have used, reported a prevalence of MetS at diagnosis of 38.2% in a multi-ethnic cohort; in addition, they found that $41% of the Hispanic subjects presented with MetS, results that are similar to the ones we found in our study [19] . The higher prevalence of MetS (and in particular of MetS WC) among our Hispanic patients and those from Parker et al.'s [19] international inception cohort could be explained not only by the definition used for MetS, but also by cultural factors among the SLE Hispanic patients from this cohort, such as the ingestion of a carbohydrate-rich diet, the more frequent use of steroids (and at higher doses) [19] and possibly by genetic factors, which may account for the higher BMI reported among them [20] . The prevalence of the other MetS criteria in our patients was similar to those previously reported in other studies [6, 19] .
Our study has some limitations. First, this was a crosssectional study, thus a temporal relationship between T cell subpopulations and MetS cannot possibly be established. Second, the cross-sectional nature of the data available precluded us from calculating the cumulative dose of prednisone, among other variables that can increase the risk for MetS. Despite these limitations, we consider it important to report this association, which should prompt the conduction of longitudinal studies to determine the temporal relationship between T cell subpopulations and MetS. Furthermore, the association between T cell subpopulations, which could be reflective of immunosenescence, and the presence of MetS could help us to understand the underlying pathogenesis of cardiovascular morbidity in SLE patients.
In conclusion, we describe for the first time a negative association between the proportion of naive CD4 + T cells and MetS and a positive association between the proportion of memory CD4 + T cells and the memory:naive CD4 + T cell ratio and MetS, independent of other wellknown risk factors. These associations should be further explored in longitudinal studies to determine their temporal relationship.
